 | Up a level |
Jump to: 2021
Number of items: 1.
2021
Schliemann, C., Pink, D., Floercken, A., Ahrens, M., Egerer, G., Goetze, K., Palmerini, E., Stacchiotti, S., Grignani, G., Rutkowski, P., Ullrich, R., Strapatsas, J., Hemmerle, T., Neri, D. and Kessler, T. (2021). A phase III study comparing the efficacy of the combination of doxorubicin and the tumor-targeting human antibody-cytokine fusion protein L19TNF to doxorubicin alone as first-line therapy in patients with advanced or metastatic soft tissue sarcoma. Ann. Oncol., 32. S. S1127 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041